N. Tyagarajan V - 01 Dec 2022 Form 4 Insider Report for Genpact LTD (G)

Role
President and CEO, Director
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan
Issuer symbol
G
Transactions as of
01 Dec 2022
Net transactions value
-$3,959,365
Form type
4
Filing time
05 Dec 2022, 16:32:52 UTC
Previous filing
03 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Options Exercise $967,500 +50,000 +7.8% $19.35 694,377 01 Dec 2022 Direct
transaction G Common Shares Sale $2,307,280 -50,000 -7.2% $46.15 644,377 01 Dec 2022 Direct F1
transaction G Common Shares Options Exercise $967,500 +50,000 +7.8% $19.35 694,377 02 Dec 2022 Direct
transaction G Common Shares Sale $2,292,945 -50,000 -7.2% $45.86 644,377 02 Dec 2022 Direct F2
transaction G Common Shares Options Exercise $967,500 +50,000 +7.8% $19.35 694,377 05 Dec 2022 Direct
transaction G Common Shares Sale $2,261,640 -50,000 -7.2% $45.23 644,377 05 Dec 2022 Direct F3
holding G Common Shares 10,000 01 Dec 2022 By Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -4.2% $0.000000 1,150,000 01 Dec 2022 Common Shares 50,000 $19.35 Direct F5
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -4.3% $0.000000 1,100,000 02 Dec 2022 Common Shares 50,000 $19.35 Direct F5
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -4.5% $0.000000 1,050,000 05 Dec 2022 Common Shares 50,000 $19.35 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.95 to $46.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.61 to $46.092. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.02 to $45.555. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
F5 The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Remarks:

The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.